ImaCor Hemodynamic Management
In This Issue
ImaCor Inc. Offers Evidence-Based Healthcare Economics of hTEE
Intraoperative Use of the ImaCor TEE Probe in Orthotopic Liver Transplantations
Pellerito's Corner
ImaCor
 
Monday, 
December 12th, 2011 
 
6:30 AM - 8:30 AM 
 
NY Marriott Marquis, Ziegfeld Room, 4th floor
 
Objectives: 
1) Know the progression of hemodynamic monitoring in the ICU over the last four decades 
2) Understand the principles 
of hemodynamic transesoph-ageal echocardiography (hTEE
3) Understand the bedside clinical application of hTEE in critically ill patients. 
"Better fluid management through direct visualization
of LV size
and function"


- Luc Frenette, MD
The University of Alabama 
at Birmingham

Contact Us

 

imacorinc.com 

 

 

 
 
1-516-393-0970

 

 

ImaCor Inc. Offers Evidence-Based Healthcare Economics of hTEE (First in a Series)
A five-year study[1] of 343,555 admissions to 83 ICUs and 31 US hospitals, which appeared in the BMC Medical Informatics and Decision Making 2010, provides a predictive model for the early identification of patients at risk for a prolonged intensive care unit length of stay (LOS)1. In this study, patients entering their fourth day in the ICU have increased risk of an extended LOS and use a disproportionate share of resources1
ImaCor
Doctors can now use hTEE to manage patients with an increased risk of an extended LOS in the ICU, while mitigating these critical care inefficiencies... 
                                                                                           Read More
Intraoperative Use of the ImaCorTM TEE Probe in Orthotopic Liver Transplantations
With a Preface by Harold Hastings PhD, Co-Founder and CTO of ImaCor Inc. 

...We announce here the first 40-patient liver transplant study demonstrating the successful use of the miniaturized ImaCor hTEE transesophageal probe for hemodynamic management, reported by Drs. Sheils, David and Frenette, from the University of Alabama at Birmingham Hospital, at the 2011 meeting of the American Association for the Study of Liver Disease (Sheils, David, Frenette, Intraoperative Use of the Imacor™ TEE Probe in Orthotopic Liver Transplantation, Abstract 668, AASLD meeting, San Francisco, Nov. 2011)....

UAB Logo
Intraoperative Use of the Imacor™ TEE 
Probe in Orthotopic Liver Transplantation 
Steven Sheils MD, David Corbett MD, 
Luc Frenette MD 
University of Alabama at Birmingham 

Introduction: Hemodynamic instability secondary to volume fluctuations during orthotopic liver transplantation (OLT) influences outcome1. . .
                                                                                      Read More
 
ImaCor Inc. was pleased to present our ZuraTM system and ClariTEE® probe at the annual meetings of the Society of Critical Care Anesthesiologists (SOCCA) in Chicago, IL on October 14th and the associated American Society of Anesthesiologists (ASA) from October 15-19, 2011. We also hosted an evening reception at SOCCA attended by a group of 50 doctors and industry professionals. The topic of the event was Hemodynamic TEE.
At the reception, Robert N. Sladen, MD, FCCM of Columbia University College of Physicians and Surgeons provided introductory remarks, and Chad E. Wagner, MD of Vanderbilt University Medical Center, as guest speaker, presented several hTEE clinical cases performed by physicians at his institution. 

As we continue to introduce the newest advances in hTEE imaging, I am delighted to announce that just this week we installed our technology at UZ Leuven in Belgium. This is our seventh European site installed since mid-September 2011.

Finally, we will be exhibiting at Booth #324 during the upcoming 65th Annual PostGraduate Assembly in Anesthesiology (PGA) from December 10-12, 2011. We invite you to join us during the assembly for a CME breakfast symposium on December 12th.  All who are interested in attending the event can register at www.iame.com/tee. We look forward to seeing you there!

With kind regards,

Peter Pellerito
President & CEO